Pharmaceutical products are estimated at 34.9% by product type in 2026 and over the counter supplements at 39.0% by sales channel. Demand follows pregnancy-specific nutrient guidance and broad retail access, but formulation variability and gastrointestinal tolerance can interrupt repeat use after initial purchase.